Answers are grounded in this paper and cite their sources.
Background/Objectives: Acute myeloid leukemia (AML) is associated with the remodeling of the bone marrow microenvironment, including reported M2-like macrophage polarization and STAT3-associated signaling. Interleukin-10 (IL-10) and oncostatin M (OSM) are candidate circulating correlates of this state, but their combined diagnostic, induction-associated, and clinical relationships in AML are poorly characterized. This exploratory study evaluated serum IL-10 and OSM as circulating biomarkers potentially linked to the AML-associated immunoregulatory microenvironment. Methods: Forty-two newly diagnosed AML patients (nine aged <18 years) were prospectively enrolled at a single center. Serum was collected at diagnosis (pre-induction; n = 32), 28 days after the start of induction (post-induction; n = 20, all matched), and from 21 healthy volunteers. Serum IL-10 and OSM were quantified by sandwich ELISA (detection ranges 1.56–100 and 15.63–1000 pg/mL, respectively) and evaluated in relation to hematological, biochemical, and clinical parameters (correlations, n = 31), remission, and overall survival (n = 34; cytokine models n = 25). Results: Both cytokines completely separated AML patients from healthy volunteers within this study cohort (AUC = 1.000 for each) and declined after induction while remaining above control levels; although, this finding requires external validation. Pre-induction OSM correlated inversely with lymphocyte percentage (ρ = −0.60, p < 0.001), and positively with granulocyte percentage (ρ = +0.65, p < 0.001), reciprocal components of one three-part differential; both remained significant after Bonferroni correction and persisted in adults only. The lymphocyte association was attenuated after adjustment for blast percentage, whereas the granulocyte association was not; absolute lymphocyte count was not reduced. Neither cytokine correlated significantly with blast burden, remission status or survival status, and no association with survival was detected. A combined IL-10 + OSM panel showed no cross-validated advantage over IL-10. Conclusions: IL-10 and OSM were markedly elevated at diagnosis, declined after induction, and differed in their associations, with OSM tracking a myeloid-skewed differential whereas IL-10 showed only nominal associations, supporting them as biologically distinct circulating correlates of an AML-associated immunoregulatory microenvironment. These findings are compatible with, but do not demonstrate, a convergent macrophage/stromal–STAT3 framework. Because macrophage phenotype, OSMR expression and pSTAT3 were not measured, this framework requires direct cellular validation, together with disease controls and independent cohorts.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: